Y-mAbs Therapeutics gains over 14% on FDA approval of DANYELZA in neuroblastoma patients Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Y-mAbs Therapeutics (YMAB) up 14.3% after getting FDA approval of DANYELZA
LOWER -
- R.R. Donnelley (RRD) down 8.7% after exiting S&P SmallCap 600 index
- DPW Holdings (DPW) down 6.6% after equity offering
- Microbot (MBOT) down 3.8% after equity offering
- Green Brick (GRBK) down 2.1% after equity offering
Symbols:
YMAB RRD DPW MBOT GRBK Keywords: fly intel, wall street, afterhours, movers, top stories, stocks